At the Annual General Meeting, Gemabank (IMCB, MOEX: GEMA) shareholders resolved to pay dividends of RUB 2.20 per ordinary share, with the record date set for June 24, 2024.
At the Annual General Meeting of Shareholders, the 2023 annual report was also approved. The report is available for review on the investor website.
IMCB is a part of the Artgen Biotech Group (MOEX: ABIO). Gemabank is a biotechnology company specializing in personalized stem cell storage and the development of gene therapy drugs for the treatment of blood and immune system diseases.